Polyganics Goes Shopping For Technology And Talent
This article was originally published in Start Up
Executive Summary
The Netherlands-based biomaterials start-up intends to expand its platform's reach through strategic partnerships and tuck-in acquisitions.
You may also be interested in...
Polyganics Initiates Clinical Trial For Actiseal Surgical Patch
The Dutch company received the US FDA's breakthrough device designation in 2018 for the surgical patch.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: what Amgen’s $3.7bn ChemoCentryx buy means; Lilly’s CEO on US drug pricing legislation; Pfizer’s GBT acquisition; new data for Amgen’s KRAS inhibitor combo; and a major China ADC alliance for Sanofi.
SyncThink Brings Eye-Sync Neurological Diagnostic To Europe
SyncThink recently obtained a CE mark for the Eye-Sync system, using the PicoXR Neo 3 Pro Eye virtual-reality headset, to measure and quantify eye-movement biomarkers reflective of neurological impairment or disease.